Cryopreservation

摘要

The role of Dohmeyer's freezing solutions in the quest to find a coronavirus vaccine Founded in 2003 and with more than 3,500 references in 62 countries across the world, Dohmeyer is well placed to share its observations of the cryogenic processing market from an equipment design and supply perspective. The company has been incredibly busy for the past 24 months. The global coronavirus (Covid-19) pandemic has had a marked effect on the industry and delayed investment decisions within its traditional customer base. Dohmeyer, however, has been approached and become the chosen partner of many pharmaceutical companies for its experience and expertise in designing equipment for new and modified applications.